Still no animal protection data, only unpublished immunogenicity data, but the staging and running all the different aspects needed for movement through clinical trials is unprecedented and offers hope for this and other countermeasure candidates to get accelerated consideration.
The mRNA-1273 #COVID19 vaccine candidate from @moderna_tx has gotten the green light from @US_FDA to move to Phase II. No data is currently available from their n=105 Phase I (safety + immunogenicity), but this is exciting news.https://www.barrons.com/articles/moderna-coronavirus-vaccine-covid-19-phase-2-approval-fda-51588857786 …
-
-
-
Yup, agreed all around!
Einde van gesprek
Nieuw gesprek -
-
-
I would be wary of that happening without clinical proof since this is one of the companies that was part of the
#InsiderTrading scheme by that group of senators. I have the info saved if you want it. I’ll find it. -
I would like to see anything you have on Moderna and how it operates. I am becoming convinced that many investors are being misled on its success. No data has been provided for its COVID vaccine--FDA keeps giving it approvals that no other company would be able to get w/o data.
- Nog 2 antwoorden
Nieuw gesprek -
-
-
is it known which dosing is being utilized for Phase2? I would imagine its not all the 3 different doses?
Bedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken
-
Het laden lijkt wat langer te duren.
Twitter is mogelijk overbelast of ondervindt een tijdelijke onderbreking. Probeer het opnieuw of bekijk de Twitter-status voor meer informatie.